Timetable

Immediate -- three months duration

Secure funding for short-term phase

Complete prototype testing on tissue analogs

Short-term -- six months duration

Obtain Institutional Review Board approval for subject testing

Complete preclinical testing on 40-50 subjects

Secure funding for medium-term phase

Medium-term -- six months duration

Complete clinical testing of biopsy guide with tissue mapping

Obtain FDA approval for marketing biopsy guide

Begin full clinical trials for Pap test replacement

Secure funding for long-term phase

Long-term -- eighteen months duration

Complete clinical trials for Pap test replacement

Apply for FDA approval for Pap test replacement

Long-term -- three to six months duration

Obtain FDA approval for Pap test replacement

Market Pap test replacement